InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,963.74
(
-1.22%
)
US TECH 100
20,836.00
(
-1.64%
)
Dow Jones
42,945.98
(
-0.88%
)
Brent Oil
73.83
(
1.28%
)
Bitcoin
94,402.12
(
-1.34%
)

Anteris Technologies Ltd (fka AMEUF)

2
Follow
2

Anteris Technologies Ltd (fka AMEUF)

2
Follow
2
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up
Live Updating
profile icon
Renee PremiumMember
05/29/20 4:55 PM
Post #1
Last Read

Anteris Technologies Ltd (fka AMEUF) RSS Feed

Followers
2
Posters
1
Posts (Today)
0
Posts (Total)
1
Created
01/04/15
Type
Free
Moderators
Admedus Corp. is the American arm of Australian ASX-listed Admedus Ltd – a diversified healthcare company focused on developing and commercializing next generation technologies with global potential. Specifically, Admedus is developing a new generation of tissue bio-implants that more easily integrate into recipient tissue, show less capacity for rejection and have the potential to replace many of the products that surgeons currently use. Our patented ADAPT™ tissue engineering process produces implantable biological scaffolds that more closely mimic the characteristics of normal human tissue. This promotes a more tolerant immune response with improved tissue in-growth. Tissue exposed to the ADAPT™ process has been shown to have significantly improved functionality and longer term durability of the resulting bio-implant. With the potential for a product lifespan free from calcification, clinicians may be able to intervene across a broader age spectrum and provide their patients with a solution for life.
Board Info
Posts Today
0
Posts (Total)
1
Posters
1
Moderators
New Post